Antiproteasic agents in the prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Cavallini
Giorgio
G
Department of Surgical and Gastroenterological Sciences, University of Verona, Italy.
Frulloni
Luca
L
D000818:Animals; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D010195:Pancreatitis / Q000201:enzymology / Q000209:etiology* / Q000517:prevention & control*; D011480:Protease Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D011480:Protease Inhibitors